Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system

Bioactive Materials

Volumn 2, Issue 4, 2017, Pages 269-280

  Dave, Vivek ^a   Yadav, Renu Bala ^a   Kushwaha, Kriti ^a   Yadav, Sachdev ^a   Sharma, Swapnil ^a   Agrawal, Udita ^b  

^a BANASTHALI UNIVERSITY   (India)

^b Sagar Institute of Research and Technology   (India)

Author keywords

Antimicrobial activity; Carbopol gel; Lipid polymer hybrid nanoparticles; Norfloxacin

Indexed keywords

ACETIC ACID; CARBOMER; DICHLOROMETHANE; DRUG CARRIER; LIPID POLYMER HYBRID NANOPARTICLE; NANOPARTICLE; NORFLOXACIN; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; POLYVINYL ALCOHOL; TRIETHANOLAMINE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; ENCAPSULATION; INFRARED SPECTROSCOPY; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; SKIN IRRITATION; THERMOGRAVIMETRY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; ZETA POTENTIAL; ZONE OF INHIBITION;

EID: 85042267186     PISSN: 2452199X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bioactmat.2017.07.002     Document Type: Article

References (27)

1. Bratu, I., Borodi, G., Kacso, I., Moldovana, Z., Filip, C., et al. New solid form of Norfloxacin: structural studies. Spectroscopy 25 (2011), 53–62.
2. Xiao, Y.W., Strategies for optimizing polymer-lipid hybrid nanoparticle-mediated drug delivery. Expert Opin. Drug Del. 13 (2016), 609–612.
3. Dua, K., Kavita, P., Ramana, M.V., Preparation, characterization and in vitro evaluation of accecloffenac solid dispersions. Ars Pharm. 51 (2010), 57–76.
4. Liua, Y., Pana, J., Feng, S.S., Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Int. J. Pharmaceu. 395 (2010), 243–250.
5. Gurny, R., Peppas, N., Harrington, D., Banker, G., Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Dev. Ind. Pharm. 7 (1981), 1–25.
6. Cheow, W.S., Hadinoto, K., Factors affecting drug encapsulation and stability of lipid–polymer hybrid nanoparticles. Colloids Surf. B 85 (2011), 214–220.
7. Agrawal, U., Gupta, M., Vyas, S.P., Capsaicin delivery into the skin with lipidic nanoparticles for the treatment of psoriasis. Artif. Cells Nanomed. Biotechnol., 2013, 10.3109/21691401.2013.832683.
8. Sahu, A.K., Verma, A., Development and statistical optimization of chitosan and eudragit based gastroretentive controlled release multiparticulate system for bioavailability enhancement of metformin HCl. J. Pharmaceu. Investig. 46 (2016), 239–252, 10.1007/s40005-016-0229-0.
9. Box George, E.P., Hunter, J.S., Hunter, W.G., Statistics for Experimenters: Design, Innovation, and Discovery. second ed., 1978, Wiley, NewYork, 510.
10. Li, Y., Wong, H.L., Shuhendler, A.J., Rauth, A.M., et al. Molecular interactions, internal structure and drug release kinetics of rationally developed polymer-lipid hybrid nanoparticles. J. Contr. Rel. 1 (2008), 60–70.
11. Shah, P., Desai, P., Singh, M., Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen. J. Contr. Rel. 158 (2012), 336–345.
12. Ranjan, O.P., Shavi, G.V., Nayak, U.Y., Arunuqam, K., Averineni, R.K., et al. Controlled release chitosan microspheres of mirtazapine: in vitro and in vivo evaluation. Arch. Pharm. Res. 11 (2011), 1919–1929, 10.1007/s12272-011-1112-1.
13. Babu, R.J., Kanikkannan, N., Kikwai, L., Ortega, C., Andega, S., et al. The influence of various methods of cold storage of skin on the permeation of melatonin and nimesulide. J. Control Rel. 86 (2003), 49–57.
14. Zhao, P., Wang, H., Yu, M., Liao, Z., Wang, X., et al. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 81 (2012), 248–256.
15. Narvekar, M., Xue, H.Y., Wong, H.L., A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). Pharm. Nano. Tech. Int. J. Pharmaceu. 436 (2012), 721–731.
16. Jubie, S., Rajeshkumar, R., Yellareddy, B., Siddhartha, G., Sandeep, M., et al. Microwave assisted synthesis of some novel benzimidazole substituted Fluoroquinolones and their antimicrobial evaluation. J. Pharmaceu. Sci. Res.(2), 2010, 69–76.
17. ICH Q1A (R2), Stability Testing of New Drug Substances and Products, International Conference on Harmonization, 2003, U.S. Department of Health and Human Service Food and Drug Administration, 4–20 CPMP/ICH/2736/99.
18. Liua, Y., Pana, J., Feng, S.S., Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Int. J. Pharm. 395 (2010), 243–250.
19. Ling, G., Zhang, P., Zhang, W., Sun, J., Meng, X., et al. Development of novel self-assembled DS-PLGA hybrid nanoparticles for improving oral bioavailability of vincristine sulfate by P-gp inhibition. J. Contr. Rel. 148 (2010), 241–248.
20. Trapani, A., Laquintana, V., Denora, N., Lopedota, A., Cutrignelli, A., et al. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies. Eur. J. Pharm. Sci. 30 (2007), 64–74, 10.1016/j.ejps.2006.10.003.
21. Song, X., Zhao, Y., Wu, W., Bi, Y., Cai, Z., Chen, Q., PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: systematic study of particle size and drug entrapment efficiency. Int. J. Pharm. 35 (2008), 320–329.
22. Hasan, W., Chu, K., Gullapalli, A., Dunn, S.S., et al. Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer. Nano Lett. 12 (2011), 287–292.
23. Harer, S.L., Rajurkar, V.G., Patil, P., Harer, P.S., et al. Synthesis, characterization and anti-microbial evaluation of some 2-Iodo-N'-[(1e)-substituted phenylmethylidene] benzohydrazide analogues. Int. J. Pharmaceu. Sci. Drug Res. 2 (2010), 134–136.
24. Shah, R., Eldridge, D., Palombo, E., Harding, I., Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J. Phys. Sci. 1 (2014), 59–75.
25. Dixit, A.R., Rajput, S.J., Patel, S.G., Preparation and bioavailability assessment of SMEDDS containing valsartan. AAPS Pharm. Sci. Tech. 11 (2010), 314–321.
26. Narvekar, M., Xue, H.Y., Wong, H.L., A novel hybrid delivery system: polymer-oil nanostructured carrier for controlled delivery of highly lipophilic drug all-trans-retinoic acid (ATRA). Pharm. Nano Tech. Int. J. Pharmaceu. 436 (2012), 721–731.
27. Müllera, R.H., Radtkeb, M., Wissingb, S.A., Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv. Drug Del. Rev. 1 (2002), S131–S155.